In June, 23andMe (NASDAQ: ME) officially finished the process of going public via a special purpose acquisition company (SPAC). These investment vehicles were popular in early 2021, but many have lost value in recent months. This includes 23andMe stock, which currently sits almost 50% below its all-time high.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,